REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,330
-20 (-0.18%)
At close: Aug 8, 2025, 3:30 PM KST

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 205.42 billion as of August 14, 2025. Its market cap has decreased by -21.68% in one year.

Market Cap
205.42B
Enterprise Value
402.29B
Revenue
148.04B
Ranking
n/a
PE Ratio
50.90
Stock Price
11,330.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 205.42B, an increase of 24.83%. That is a compound annual growth rate of 1.47%.

History

DateMarket Cap% Change
Aug 14, 2025205.42B-12.77%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 73.52T
Celltrion 38.80T
ALTEOGEN 23.35T
Yuhan 8,487.38B
Peptron 8,235.61B
SK Biopharmaceuticals 7,878.31B
PharmaResearch 6,909.12B
LigaChem Biosciences 5,666.20B
Market Cap Rankings